Extended-Release Injectable Naltrexone for the Treatment of Opioid Dependence

$3.00 | CEU Hours:1.00 | Intermediate

*This course is not approved for NBCC renewal. Please see our NBCC category of courses here.

CEU Course Description

This course was developed from the Substance Abuse and Mental Health Services Administration advisory which provides behavioral health professionals - including substance abuse treatment specialists - and primary care medical providers (who treat people with opioid dependence) with an introduction to extended-release injectable naltrexone.  The advisory also includes succinct information about extended-release injectable naltrexone, how it compares with other medication-assisted treatment (MAT) options, and clinical strategies that may be used to select, initiate, and administer treatment.

 

CEU Course Objectives

1.  Identify which health care professionals are able to prescribe extended-release injectable naltrexone.

2.  Enumerate which substances are opioid agonists and which are opioid antagonists.

3.  Become familiar with the proper way to administer extended-release injectable naltrexone.

Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degree of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff here.

*Board Approvals for this course can be found here.
*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.

Powered by LIFTOFF Digital | Web Design and Development